Drug Database
HP

HPV-16/18 (Cecolin)

✓ Approved

Beijing Wantai Biological Pharmacy · · Recombinant Proteins

What is HPV-16/18?

HPV-16/18 is a recombinant proteins developed by Beijing Wantai Biological Pharmacy. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection.

Drug Profile

Brand NamesCecolin
CompanyBeijing Wantai Biological Pharmacy
Drug ClassRecombinant Proteins, Vaccine
Molecular Target,
RouteInjectable (Others), Intramuscular (IM) Injection
StatusApproved
Sources: ClinicalTrials.gov, Beijing Wantai Biological Pharmacy

Mechanism of Action

Molecular Targets

HPV-16/18 acts on 2 molecular targets:

(E7)
(E7)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

HPV-16/18 is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Infections and infestationsPapilloma viral infection✓ Approved

Related Research Articles

Unable to load articles right now.

Ask about HPV-16/18